Involvement of soluble CD95 in Churg-Strauss syndrome

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 915-925

  Müschen, Markus ^a,b   Warskulat, Ulrich ^a,c   Perniok, Andreas ^a   Even, Jos ^b   Moers, Cordula ^a   Kismet, Berrin ^a   Temizkan, Nazan ^a   Simon, Dietmar ^a   Schneider, Matthias ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL KILLING; CELL SURVIVAL; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; GENE MUTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; T LYMPHOCYTE;

EID: 0345411582     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65191-7     Document Type: Article

References (26)

1. Churg J, Strauss L: Allergic granulomatosis. Allergic angiitis, and periarteriitis nodosa. Am J Pathol 1951, 27:277-301
2. Modigliani R, Muschart JM, Galian A, Clauvel JP, Desruisseaux JL: Allergic granulomatous vasculitis: report of a case with digestive involvement. Dig Dis Sci 1981, 26:264-270
3. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome. Arthritis Rheum 1990, 33:1094-1102
4. Lanham GJ, Elkon KB, Pusey CD, Hughes GR: System vasculitis with asthma and eosinophilia a clinical approach to the Churg-Strauss syndrome. Medicine 1984, 63:65-81
5. Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL: Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998, 41:445-452
6. Pannetier C, Even J, Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples, Immunol Today 1995, 16:176-181
7. Davis MM, Bjorkmann PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988, 334:395-402
8. Génevée C, Diu A, Nierat J, Caignard A, Dietrich PY, Ferradini L, Roman-Roman S, Triebel F, Hercend T: An experimentally validated panel of sublamily-specific oligonucleotide primers (Vα1-W29/Vβ1-W24) for the study of human T-cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992, 22:1261-1269
9. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317
10. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989, 245:301-305
11. Hughes DPM, Crispe NI: A naturally occurring soluble isoform of murine Fas generated by alternative splicing, J Exp Med 1995, 182: 1395-1401
12. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994, 263:1759-1762
13. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB: Fas gene mutations in the Canale-Smith Syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996, 335:1643-1645
14. Fisher GH, Rosenberg FJ, Strauss SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in human autoimmune lymphoproliferative disorders. Cell 1995, 81:935-946
15. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, deVillartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995, 268: 1347-1350
16. - T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996, 183:1071-1082
17. Müschen M, Warskulat U, Häussinger D, Moers C, Simon D, Even J: Derangement of CD95 system in a case of Churg-Strauss vasculitis. Gastroenterology 1998, 114:1351-1352
18. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thompson RA: Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 1989, 122:97-103
19. Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P: Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 1993, 21:577-583
20. Müschen M, Warskulat U, Douillard P, Gilbert E, Häussinger D: Regulation of CD95 (Apo-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998, 27:200-208
21. Müschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Häussinger D: Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation, Gastroenterology 1999, 116:666-677
22. Lenardo MJ: Fas and the art of lymphocyte maintenance. J Exp Med 1996, 183:721-724
23. Xerri L, Devilard E, Hassoun J, Mawas C, Birg F: Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. J Clin Pathol 1997, 50:87-91
24. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993, 90:4409-4413
25. Matsumoto K, Schleimer RP, Saito H, likura Y, Bochner B: Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995, 86:1437-1443
26. Guillevin L, Amouroux J, Arbeille B, Boura R: Churg-Strauss angiitis: arguments favoring the responsibility of inhaled antigens. Chest 1991, 100:1472-1473